AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 NOV 15 - (NewsRx.com & NewsRx.net) -- Patient awareness of potentially life-saving new breast cancer tests and treatments is woefully low among the majority of women with breast cancer across Europe, according to the results of a new survey of breast cancer patients.
Although doctors and nurses were rated as among the prime sources of breast cancer information, some patients expressed concern that information on new treatments was not always readily offered.
Overall patients demonstrated a lack of knowledge about innovative new treatments such as Herceptin (trastuzumab). While patient familiarity with older treatments such as chemotherapy was high in all countries, Germany was the only country to report high awareness levels for Herceptin at 60%, compared with only 6% in the UK. Similarly, awareness of HER2 diagnostic testing (which identifies those patients suitable for Herceptin) was only 17% overall.
Susan Knox, executive director of Europa Donna, the European Breast Cancer Coalition, commented, "Unlike other illnesses, breast cancer is a disease in which a woman needs to understand the treatments available and the probable ...
Source: HighBeam Research, European Survey Exposes Poor Patient Awareness Of Treatment...